A61P

Watch

Stats

Description

THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

Subclasses

Not Available
Subclass Title
1/00 Drugs for disorders of the alimentary tract or the digestive system
1/02 Drugs for disorders of the alimentary tract or the digestive system Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
1/04 Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
1/06 Drugs for disorders of the alimentary tract or the digestive system Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
1/08 Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

more results

Recent Patents

Not Available

Recent Publications

Not Available
Publication #TitleFiling DatePub DatePatent Owner
2020/0017,585 ANTIBODY TO FIBROSIS-RELATED MOLECULE AND MEDICAL APPLICATION THEREOF Dec 01, 17 Jan 16, 20 , THE UNIVERSITY OF TOKYO
2020/0017,857 Methods of Treating Porphyria Jul 12, 19 Jan 16, 20 , Not available
2020/0017,909 HUMAN GENETIC MARKERS ASSOCIATED WITH RESPONSE TO TREATMENTS THAT TARGET CLOSTRIDIUM DIFFICILE TOXIN B Dec 07, 17 Jan 16, 20 , Merck Sharp & Dohme Corp.; Beijing Genomics Institute at Shenzhen;
2020/0016,145 TREATMENT OF CHRONIC TRAUMATIC ENCEPHALOPATHY Jul 10, 19 Jan 16, 20 , CTEC LLC
2020/0016,276 ANTIBODY-DRUG CONJUGATES BASED ON GOLD COMPOUNDS Jul 05, 19 Jan 16, 20 , Not available
2020/0016,205 Suppression of Microglial Activation with Innate Lymphoid Cells Jun 25, 19 Jan 16, 20 , Not available
2020/0017,520 HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS Aug 26, 19 Jan 16, 20 , Not available
2020/0016,129 COMPOUNDS FOR USE IN THE PREVENTION AND/OR TREATMENT OF NON-ALCOHOLIC FAT LIVER DISEASE AND NON-ALCOHOLIC STEATOHEPATITIS Feb 19, 18 Jan 16, 20 , Not available
2020/0016,104 COMPOSITIONS AND METHODS FOR THE TREATMENT OF FAT INFILTRATION IN MUSCLE Jun 19, 19 Jan 16, 20 , Not available
2020/0016,128 THERAPEUTIC USE OF LEVOROTATORY B-LACTAMS IN HEMATOPOIESIS, IMMUNO-ONCOLOGY THERAPY, AND REGULATION OF LIPOPROTEIN AND APOLIPOPROTEIN LEVELS Aug 19, 19 Jan 16, 20 , Not available
2020/0017,600 VARIANTS OF CD38 ANTIBODY AND USES THEREOF Jul 15, 19 Jan 16, 20 , Not available
2020/0016,125 GRANZYME B INHIBITOR COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF SKIN BLISTERING AND/OR PEELING Feb 28, 18 Jan 16, 20 , The University of British Columbia
2020/0016,209 METHODS RELATED TO ENGINEERED ERYTHOID CELLS COMPRISING 4-1BBL Sep 18, 19 Jan 16, 20 , Not available
2020/0016,121 COMPOUNDS AND METHODS FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE WITH EXTRA-INTESTINAL MANIFESTATIONS Feb 16, 18 Jan 16, 20 , Not available
2020/0016,163 TREATMENT OF DEMENTIA WITH CANNABINOID AGONISTS Feb 23, 18 Jan 16, 20 , Not available
2020/0017,590 NOVEL ANTI-TRKB ANTIBODIES Mar 15, 18 Jan 16, 20 , Not available
2020/0016,124 COMPOSITIONS AND METHODS FOR REDUCING WEIGHT GAIN Jul 15, 19 Jan 16, 20 , Not available
2020/0017,523 Methods of Treating or Preventing Autoimmune Diseases with 2,4-Pyrimidinediamine Compounds Mar 21, 19 Jan 16, 20 , Rigel Pharmaceuticals Inc.
2020/0017,452 MATRIX METALLOPROTEINASE-9 HEMOPEXIN DOMAIN INHIBITORS AND METHODS OF TREATMENT USING SAME Mar 22, 18 Jan 16, 20 , Not available
2020/0017,853 COMPOSITIONS AND METHODS FOR PAIN AMELIORATION VIA MODIFICATION OF GENE EXPRESSION Feb 28, 17 Jan 16, 20 , Not available

more results

Patents Issued To Date - By Filing Year

Average Time to Issuance

We are sorry but your current selection exceeds the maximum number of watches () for this membership level. Upgrade to our Level for up to watches!

UPGRADE MEMBERSHIP CANCEL
We are sorry but Dashboard Viewer is not able to watch the Technologies/Sub-Technologies.